Controlled ovarian hyperstimulation pharmacogenetics: a simplified model to genetically dissect estrogen-related diseases

Author： Morón Francisco Jesús   Galán José Jorge   Ruiz Agustín  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.8, Iss.7, 2007-07, pp. : 775-785

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Pharmacogenetics of controlled ovarian hyperstimulation

By de Castro Francisco   Morón Francisco J   Montoro Luis   Real Luis M   Ruiz Agustín  

Pharmacogenomics, Vol. 6, Iss. 6, 2005-09 ,pp. : 629-637

Future Medicine

Access to resources Recommend Favorite

The Role of Estrogen and Estrogen-Related Drugs in Cardiovascular Diseases

By  

Current Drug Metabolism, Vol. 4, Iss. 6, 2003-12 ,pp. : 497-504

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetics of controlled ovarian hyperstimulation: time to corroborate the clinical utility of FSH receptor genetic markers

By Morón Francisco Jesús   Ruiz Agustín  

Pharmacogenomics, Vol. 11, Iss. 11, 2010-11 ,pp. : 1613-1618

Future Medicine

Access to resources Recommend Favorite

Estrogen-Related Receptors as Emerging Targets in Cancer and Metabolic Disorders

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 3, 2006-02 ,pp. : 203-215

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advance in the Design of Small Molecular Modulators of Estrogen-Related Receptors

By  

Current Pharmaceutical Design, Vol. 18, Iss. 23, 2012-08 ,pp. : 3421-3431

Bentham Science Publishers

Access to resources Recommend Favorite